Hämostaseologie, Table of Contents Hamostaseologie 1984; 04(04): 118-122DOI: 10.1055/s-0038-1659934 Originaler Artikel Schattauer GmbH Die Bedeutung der Thrombozyten bei der Entstehung und Persistenz der Glomerulonephritis J. S. Cameron 1 Guy’s Hospital, London, U.K. › Author AffiliationsRecommend Article Abstract Buy Article Full Text References Literatur 1 Zamonbi L. Anatomy and embryology of the kidney, ureter, bladder and urethra. In: Massry S.G, Glassock R.J. (Eds.) Textbook of Nephrology. Williams & Wilkins; Baltimore: 1982: 1.3-1.27. 2 Nackman R.L, Weksler B.B. The platelet as in inflammatory cell. In: Weissman G. (Ed.) Cell Biology and Inflammation. Elsevier; Amsterdam: 1980: 145-162. 3 Zimmerman T.S, Fierer J, RoArbergen H. Blood coagulation and the inflammatory response. Semin. Hematol. 14: 391-408 1977; 4 Holmsen H, Salganicoff L, Fukomi H. Platelet behaviour and biochemistry. In: Ogston D, Bennett B. (Eds.) Haemostasis, Physiology and Pathology. Wiley; New York: 1973: 241-319. 5 Heldin C-H, Westermark B, Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem. J. 193: 907-913 1981; 6 Nakashima Y, Hirose S, Hamashima Y. Proliferation of cultured rabbit renal glomerular cells stimulated by platelet factor. Acta Pathol. Jpn. 30: 1-7 1980; 7 Deuel T.F, Senior R.M, Chang D, Griffin G.L, Henrikson R.L, Kaiser E.T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. U.S.A. 78: 4584-4587 1981; 8 Deuel T.F, Senior R.M, Huang J.S. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 66: 1046-1049 1982; 9 Dunn M.J. The role of arachidonic acid metabolites in glomerulonephritis. In: Remuzzi G, Bertani T. (Eds.) Glomerular Injury 300 Years After Morgagni. T. Wichtig; Milan: 1983 10 Polley M.J, Nachman R. The human complement system in thrombin-mediated platelet function. J. Exp. Med. 147: 1713-1726 1978; 11 Humphrey J.H, Jaques R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J. Physiol. 128: 9-17 1955; 12 Henson P.M, Spiegelberg H.L. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and sub-classes. J. Clin. Invest. 52: 1282-1288 1973; 13 Clark W.E, Teraarwerk G.M, Bandali K, Lindsay R.M, Linton A.L. Platelet aggregation and release associated with immune complex formation in pig plasma. J. Lab. Clin. Med. 90: 654-665 1980; 14 Benveniste J, Henson P.M, Cochrane C.G. Leukocyte-dependent histamine release from rabbit platelets. J. Exp. Med. 136: 1356-1377 1972; 15 Benveniste J, Jouvin E, Pirotzky E, Arnoux B, Mencia-Huerta J.M, Roubin R, Vargaftig B.B. Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions. Int. Arch. Allerg. Appl. Immunol. 66 (Suppl. 01) 121-126 1981; 16 Camussi G, Tetta C, Coda R, Benveniste J. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus. Lab. Invest. 44: 241-251 1981; 17 Camussi G, Bosio D, Sergoloni G, Tetta C, Vercellone A. Evidence for the involvement of the IgE-basophil-mastocyte system in human acute poststreptococcal glomerulonephritis. La Ricerca 8: 56-64 1978; 18 Martini A, Levy M, Broyer M, Hirsch J.F, Benveniste J. Sensibilisation des basophiles envers le staphylocoque au cours d’une glomerulonéphrite secondaire à l’infection d’une déviation ventriculo-atriale. J. Urol. Néphrol. 84: 349-353 1978; 19 George C.R.P, Slichter S.C, Qudracci L.J, Striker G.E, Harker L.A. A kinetic evaluation of hemostasis in renal disease. New Engl. J. Med. 293: 1111-1115 1974; 20 Clark W.F, Lewis M.L, Cameron J.S, Parsons V. Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. Clin. Sci. Mol. Med. 49: 247-252 1975; 21 Parbtani A, Frampton G, Cameron J.S. Measurements of platelet release substances in glomerulonephritis. A comparison of beta-thromboglobulin (BTG), platelet factor 4 (PF4) and serotonin assays. Thromb. Res. 19: 177-189 1980; 22 Woo K.T, Whitworth J.A, Kincaid-Smith P. Effect of antiplatelet agents on circulating platelet aggregates in patient with glomerulonephritis. Thromb. Res. 20: 663-668 1980; 23 Andrassy K, Ritz E, Mauerhoff T, Bommer J. What is the evidence for activated coagulation in glomerulonephritis?. Amer. J. Nephrol. 2: 293-300 1982; 24 Duffy J.L, Cinque T, Grishman E, Churg J. Intraglomerular fibrin platelet aggregation and subendothelial deposits in lipoid nephrosis. J. Clin. Invest. 49: 251-258 1970; 25 Parbtani A, Frampton G, Cameron J.S. Platelet and plasma serotonin concentrations in glomerulonephritis, II. Clin. Nephrol. 14: 112-123 1980; 26 Parbtani A, Frampton G, Kasai N, Yewdall V, Cameron J.S. Platelet and plasma serotonin concentrations in glomerulonephritis. III. The nephritis of systemic lupus erythematosus. Clin. Nephrol. 14: 164-172 1980; 27 Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Clin. Nephrol. 17: 24-30 1982; 28 Richman A.V, Kashic G. Endothelial and platelet reactions in the idiopathic nephrotic syndrome. Hum.. Pathol. 13: 548-553 1982; 29 Miller K, Dresner I.G, Michael A.F. Localization of platelet antigens in human kidney disease. Kidney Int. 18: 472-479 1980; 30 Duffus P, Parbtani A, Frampton G, Cameron J.S. Intraglomerular localisation of platelet-related antigens, platelet factor 4 and β-thromboglobulin in glomerulonephritis. Clin. Nephrol. 18: 298-302 1982; 31 Kasai N, Parbtani A, Yewdall V, Shepherd P, Verroust P, Cameron J.S. Platelet-aggregating immune complexes in glomerulonephritis. Clin. Exp. Immunol. 43: 64-72 1981; 32 Lavelle K.J, Noseman A.M. The influence of selective thrombocytopenia on immune complex glomerulonephritis. J. Lab. Clin. Med. 192: 737-749 1978; 33 Lavelle K.J, Ransdell B.A, Kleit S.A. The influence of selective thrombocytopenia on nephrotoxic nephritis. J. Lab. Clin. Med. 87: 967-975 1976; 34 Sindrey M, Marshall T.L, Naish P. Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin. Exp. Immunol. 36: 90-96 1979; 35 Cochrane C.G. Mechanisms involved in the deposition of immune complexes in tissues. J. exp. med. 134: 75s-89s 1971; 36 Kniker W.T. Modulation of the inflammatory response in vivo prevention of amelioration of immune complex disease. In: Lepow I.H, Ward P.A. (Eds.) Inflammation mechanisms and Control. Academic Press; New York: 1972: 335-367. 37 Bolton W.K, Spargo B.A, Lewis E.J. Chronic autologous immune complex glomerulopathy: effect of Cyproheptadine. J. Lab. Clin. Med. 83: 695-704 1974; 38 Ida T, Tomura S, Sakurai S, Chida Y, Takeuchi J. The role of platelets in BSA nephritis. Abstract No. EX 013. Abstr. 9th Congr. Int. Soc. Nephrol. Athens. 214 1981 39 Nagase M, Honda N. Possible mechanisms of antiproteinuric effect of dipyridamole in nephrotic rats induced by aminonu-cleoside. 8th Int. Congr. Pharmacol., Tokyo, (Abstr.) 1981 40 Tojo S, Narita M, Koyama A, Sano M, Suzuki H, Tsuchiya T, Tsuchida H, Yamamoto S, Shishido H. Dipyridamole therapy in the nephrotic syndrome. Contrib. Nephrol. 9: 111-127 1978; 41 Cameron J.S. The treatment of severe glomerulonephritis with combined immunosuppression and anticoagulation. Proc. Sixth Int. Congr. Nephrol., Montreal. Karger, Basel 1981, pp. 419-424. 42 Futrakul P, Poshyachinda M, Mitra-kul C. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Clin. Nephrol. 10: 180-186 1978; 43 Donadio J.V, Anderson C.F, Mitchell J.C, Holley K.E, Ilstrup D.M, Fuster V. Membranoproliferative glomerulonephritis (MPGN): a prospective clinical trial of platelet inhibitor therapy. Am. Soc. Nephrol. (Abstr.), Kidney Int. 23: 28A 1982; 44 Hugues S. Accolement des plaquettes aux structures conjonctives perivasculaires. Thromb. Diath. Haemorrh. 8: 241-245 1962; 45 Barnec M, Bailey A, Gordon J, Mclntyre D. Platelet aggregation to basement membrane-associated collagens. Thromb. Res. 18: 375-388 1980; 46 Vargaftig B.B, Chignard M, Benveniste J. Present concepts on the mechanisms of platelet aggregation. Biochem. Pharmacol. 30: 263-271 1981; 47 Bertele V, Cerletti C, Schiepatti A, di Minno G, deGaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet I: 1057-1058 1981;
